Folate deficiency has been associated with a higher risk of depressive symptoms, irritability, and other mood disturbances, likely through its role in one‑carbon metabolism, monoamine neurotransmitter synthesis, and methylation processes in the brain. Clinical and epidemiologic studies have found that people with low folate or elevated homocysteine are more likely to experience major depression, and lower folate status has been linked to poorer response to certain antidepressant medications. The encouraging clinical point is that, in folate‑deficient individuals, correcting folate status (often with folic acid or methylfolate, and alongside vitamin B12 when indicated) may improve mood symptoms and, in some cases, enhance antidepressant treatment response, especially when combined with comprehensive psychiatric and lifestyle interventions. This medication is commonly used for Hypertension.
David Mischoulon, Maurizio Fava. Folate in Depression: Efficacy, Safety, Differences in Formulations, and Clinical Issues. The Journal of Clinical Psychiatry. 2009. Gao S, Khalid A, Amini-Salehi E, Radkhah N, Jamilian P, Badpeyma M, Zarezadeh M. Folate supplementation as a beneficial add-on treatment in relieving depressive symptoms: A meta-analysis of meta-analyses. Food Sci Nutr. 2024 Mar 8;12(6):3806-3818. Reynolds EH, Crellin R, Bottiglieri T, Laundy M, Toone BK, et al. Methylfolate as Monotherapy in Depression. A Pilot Randomised Controlled Trial. J Neurol Psychol. 2015;3(1): 5. Reynolds EH. Folic acid, ageing, depression, and dementia. BMJ. 2002 Jun 22;324(7352):1512-5. Gilbody S, Lightfoot T, Sheldon T. Is low folate a risk factor for depression? A meta-analysis and exploration of heterogeneity. J Epidemiol Community Health. 2007 Jul;61(7):631-7.
Some side effects may be linked to nutrient depletion caused by this medication.
Thiamine (vitamin B1) deficiency in patients with cardiovascular disease might be linked to two factors associated with loop diuretics: increased urine output, and cellular uptake inhibition. Loop diuretics can significantly increase urine volume and urinary flow rate, potentially leading to increased thiamine excretion through urine. Emerging evidence suggests loop diuretics may directly inhibit the cellular uptake of thiamine, further contributing to deficiency. Thiamine supplementation during loop diuretic therapy should therefore be considered.
Long-term use with Loop diuretics can come with potential side effects related to nutrient depletion. One such essential nutrient that these medications can impact is potassium. Potassium plays a critical role in various bodily functions including regulating blood pressure, ensuring proper balance of fluids and electrolytes within cells, and may contribute to a lower risk of developing kidney stones and bone loss. Potassium supplementation during loop diuretic therapy should therefore be considered.
Studies indicate that Loop diuretics can act as folate antagonists, potentially leading to a deficiency. This occurs because some diuretics inhibit the enzyme responsible for utilizing folate (folic acid) in the body. Research suggests a link between long-term diuretic use (over six months) and decreased blood folate levels while also showing a significant increase in damaging homocysteine levels. Folate supplementation during loop diuretic therapy should therefore be considered.
Loop diuretics can disrupt the kidneys' ability to reabsorb magnesium, leading to increased excretion of this essential mineral through urine. This potential depletion necessitates monitoring magnesium levels, especially in individuals undergoing long-term loop diuretic therapy. Supplementing with magnesium may be beneficial in such cases to help protect against a deficiency.
Calcium, crucial for strong bones and teeth, can be depleted by loop diuretics. These medications can unfortunately decrease calcium levels in the body. To protect against a deficiency and maintain optimal bone health, individuals taking loop diuretics may benefit from calcium supplementation.